ClinicalTrials.Veeva

Menu

Menopausal Hormone Therapy And Left Ventricular Function

Mayo Clinic logo

Mayo Clinic

Status

Not yet enrolling

Conditions

Menopause
Left Ventricular Dysfunction

Treatments

Drug: Menopausal Hormone Therapy

Study type

Observational

Funder types

Other

Identifiers

NCT07242391
25-006388

Details and patient eligibility

About

The purpose of this study is to compare left ventricular stroke volume and heart rate responses to bursts of SNA between PMF using, and not using, MHT.

Enrollment

50 estimated patients

Sex

Female

Ages

45 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

• >45-60< years of age

Exclusion Criteria

  • Male sex
  • Females between STRAW+10 stages -5 and 0
  • PMF in STRAW+10 stage +2
  • PMF using oral hormone therapy
  • Females who entered menopause due to a surgical procedure or in response to pharmacotherapy (e.g., gonadotrophin releasing hormone agonists or chemotherapy)
  • Heart disease such as hypertropic cardiomyopathy, congenital abnormalities, chronic heart failure, valve disease, and a history of myocardial infarction
  • Medications that impact the central nervous system including selective serotonin reuptake inhibitors, anxiolytics, sedatives, anticholinergic agents, dopamine, amphetamines, or wake-promoting agents (e.g., modafinil). Other medications will be evaluated on an individual basis by the PI.
  • Cardiovascular medications is also an exclusion criterion which includes those acting on the renin-angiotensin-aldosterone axis, adrenergic receptor antagonists, diuretics, nitrates, and calcium channel antagonists. Other medications will be evaluated on an individual basis by the PI.
  • Pregnancy
  • COPD
  • Diabetes
  • CKD
  • Raynaud's phenomenon
  • Sleep disorders
  • Shift workers
  • BMI ≥40.0kg/m2
  • Use of nicotine-containing products within the two years preceding study visits
  • Active cancer treatment

Trial design

50 participants in 2 patient groups

Post-menopausal females using menopausal hormone therapy
Description:
Post menopausal females taking a clinically prescribed menopausal hormone therapy (i.e. pill, patch, etc.)
Treatment:
Drug: Menopausal Hormone Therapy
Post-menopausal females not using menopausal hormone therapy

Trial contacts and locations

1

Loading...

Central trial contact

Joshua Bock, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems